Sagewood Asset Management’s AstraZeneca AZN Stock Holding History

Sagewood Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$622K	Hold	3,280	–	–	0.14%	140
2026 Q1	$647K	Buy	+3,280	New	+$632K	0.2%	98

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sagewood Asset Management's AZN Position: Q2 2026 in Review

Sagewood Asset Management held its AstraZeneca (AZN) position steady in Q2 2026 at 3,280 shares worth $622K. The position accounts for 0.14% of the portfolio, ranked #140.

Sagewood Asset Management first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $647K in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Sagewood Asset Management held 3,280 shares of AstraZeneca worth $622K as of Q2 2026.
Sagewood Asset Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.14% of Sagewood Asset Management's portfolio in Q2 2026, its #140 holding.
Sagewood Asset Management first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
Sagewood Asset Management's AstraZeneca position peaked at $647K in Q1 2026.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Sagewood Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.